Condition

Revascularization

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting2

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)NCT07269366 · 2026-05-01

RECRUITING

Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With Left Ventricular Dysfunction (PROVERB)NCT05532631 · 2023-03-16

RECRUITING

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV EventsNCT00327418 · 1997-01-01

COMPLETED

Common interventions

AtorvastatinDRUG1 CABGPROCEDURE1 Coronary artery bypass graftingPROCEDURE1 PCIPROCEDURE1 Percutaneous coronary interventionPROCEDURE1

Leading sponsors

Assistance Publique - Hôpitaux de Paris 1 Pfizer 1 University Medical Center Groningen 1

Trial status mix

RECRUITING2

COMPLETED1

Phase mix

NA2

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.